Norwegian Cruise Lineの収益YQ/Q
Norwegian Cruise Lineの収益YQ/Qは何ですか。
Norwegian Cruise Line Holdings Ltd.の収益YQ/Qは955.33%です。
収益YQ/Qの定義は何ですか。
四半期収益成長率、前年比は、前年同期の業績と比較して、売上高の増加率がパーセンテージとして表されています。
Quaterly revenue growth is the amount by which revenue exceeds the revenue in a previous quarter. It is beneficial to look at a company's quarterly financials to identify how the company is performing over time not just during the current period. The usage of year over year comparison is advantageous in removing seasonalities in reporting the quarterly revenue growth and observing longterm trends.
LSEのセクタMiscellaneousにおける収益YQ/Qの企業と比べるNorwegian Cruise Line
Norwegian Cruise Lineは何をしますか。
Norwegian Cruise Line Holdings Ltd., together with its subsidiaries, operates as a cruise company in the North America, Europe, the Asia-Pacific, and internationally. The company operates the Norwegian Cruise Line, Oceania Cruises, and Regent Seven Seas Cruises brands. It offers itineraries ranging from three days to a 180-days calling on various locations, including destinations in Scandinavia, Russia, the Mediterranean, the Greek Isles, Alaska, Canada and New England, India and the rest of Asia, Tahiti and the South Pacific, Australia and New Zealand, Africa, South America, the Panama Canal, and the Caribbean. As of December 31, 2020, the company had 28 ships with approximately 59,150 berths. It distributes its products through retail/travel advisor and onboard cruise sales channels, as well as meetings, incentives, and charters. The company was founded in 1966 and is based in Miami, Florida.
Norwegian Cruise Lineと類似の収益yq/q
- Strike Resourcesの収益YQ/Qは920.00%です。
- Franchise Global Health Incの収益YQ/Qは936.52%です。
- AML3Dの収益YQ/Qは936.99%です。
- Xinghua Portの収益YQ/Qは942.98%です。
- CTI BioPharma Corpの収益YQ/Qは950.81%です。
- Genius Brands Internationalの収益YQ/Qは951.54%です。
- Norwegian Cruise Lineの収益YQ/Qは955.33%です。
- Lmp Automotive Incの収益YQ/Qは957.73%です。
- Goldgroup Miningの収益YQ/Qは957.97%です。
- Carbon Mineralsの収益YQ/Qは966.67%です。
- Sun Pharma Advanced Researchの収益YQ/Qは970.73%です。
- BioCorRxの収益YQ/Qは971.12%です。
- Re:NewCell AB (publ)の収益YQ/Qは977.63%です。